Yaffa Rubinstein

2.5k total citations
30 papers, 1.4k citations indexed

About

Yaffa Rubinstein is a scholar working on Molecular Biology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Yaffa Rubinstein has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Genetics and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Yaffa Rubinstein's work include Genomics and Rare Diseases (10 papers), Ethics in Clinical Research (7 papers) and Biomedical Text Mining and Ontologies (5 papers). Yaffa Rubinstein is often cited by papers focused on Genomics and Rare Diseases (10 papers), Ethics in Clinical Research (7 papers) and Biomedical Text Mining and Ontologies (5 papers). Yaffa Rubinstein collaborates with scholars based in United States, United Kingdom and Spain. Yaffa Rubinstein's co-authors include Seth A. Ettenberg, Marion M. Nau, Stephen C. Groft, Stan Lipkowitz, Mauricio Cuello, Jim Vaught, Daniel F. Hayes, Paula Kim, Edward Seijo and Claire S. Zhu and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Yaffa Rubinstein

29 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaffa Rubinstein United States 19 635 293 272 255 244 30 1.4k
Stella Somiari United States 17 722 1.1× 390 1.3× 289 1.1× 237 0.9× 84 0.3× 28 1.4k
Helen M. Moore United States 17 644 1.0× 452 1.5× 168 0.6× 314 1.2× 87 0.4× 37 1.3k
Paul R. Billings United States 29 522 0.8× 357 1.2× 229 0.8× 382 1.5× 532 2.2× 98 2.1k
Yineng Fu United States 9 579 0.9× 298 1.0× 106 0.4× 331 1.3× 194 0.8× 13 1.2k
Faina Linkov United States 24 364 0.6× 307 1.0× 138 0.5× 569 2.2× 157 0.6× 99 1.9k
Manabu Kuroki Japan 24 972 1.5× 199 0.7× 110 0.4× 351 1.4× 108 0.4× 95 2.7k
Manuel M. Morente Spain 25 622 1.0× 352 1.2× 323 1.2× 506 2.0× 92 0.4× 53 1.6k
Qiushi Lin United States 21 1.3k 2.1× 338 1.2× 137 0.5× 595 2.3× 295 1.2× 38 2.3k
Samuel L. Volchenboum United States 22 869 1.4× 562 1.9× 95 0.3× 354 1.4× 150 0.6× 66 1.9k
Jim Vaught United States 18 420 0.7× 336 1.1× 590 2.2× 104 0.4× 149 0.6× 38 1.3k

Countries citing papers authored by Yaffa Rubinstein

Since Specialization
Citations

This map shows the geographic impact of Yaffa Rubinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaffa Rubinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaffa Rubinstein more than expected).

Fields of papers citing papers by Yaffa Rubinstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaffa Rubinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaffa Rubinstein. The network helps show where Yaffa Rubinstein may publish in the future.

Co-authorship network of co-authors of Yaffa Rubinstein

This figure shows the co-authorship network connecting the top 25 collaborators of Yaffa Rubinstein. A scholar is included among the top collaborators of Yaffa Rubinstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaffa Rubinstein. Yaffa Rubinstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kodra, Yllka, Manuel Posada de la Paz, Alessio Coi, et al.. (2017). Data Quality in Rare Diseases Registries. Advances in experimental medicine and biology. 1031. 149–164. 41 indexed citations
2.
Rubinstein, Yaffa, Manuel Posada de la Paz, & Marina Mora. (2017). Rare Disease Biospecimens and Patient Registries: Interoperability for Research Promotion, a European Example: EuroBioBank and SpainRDR-BioNER. Advances in experimental medicine and biology. 1031. 141–147. 3 indexed citations
3.
Hansson, Mats, Hanns Lochmüller, Olaf Rieß, et al.. (2016). The risk of re-identification versus the need to identify individuals in rare disease research. European Journal of Human Genetics. 24(11). 1553–1558. 42 indexed citations
4.
López‐Martín, Estrella, Rachel Thompson, Sabina Gainotti, et al.. (2016). Overview of existing initiatives to develop and improve access and data sharing in rare disease registries and biobanks worldwide. Expert Opinion on Orphan Drugs. 4(7). 729–739. 4 indexed citations
5.
Sheehan, Jerry, Steven Hirschfeld, Erin D. Foster, et al.. (2016). Improving the value of clinical research through the use of Common Data Elements. Clinical Trials. 13(6). 671–676. 83 indexed citations
6.
Rubinstein, Yaffa & Pamela McInnes. (2015). NIH/NCATS/GRDR® Common Data Elements: A leading force for standardized data collection. Contemporary Clinical Trials. 42. 78–80. 37 indexed citations
7.
Taruscio, Domenica, et al.. (2014). A mapping study of the biomedical ontologies in the RD-Connect project framework. Figshare. 1 indexed citations
8.
Mascalzoni, Deborah, Edward S. Dove, Yaffa Rubinstein, et al.. (2014). International Charter of principles for sharing bio-specimens and data. European Journal of Human Genetics. 23(6). 721–728. 104 indexed citations
9.
Groft, Stephen C. & Yaffa Rubinstein. (2013). New and Evolving Rare Diseases Research Programs at the National Institutes of Health. Public Health Genomics. 16(6). 259–267. 15 indexed citations
10.
Hammond, E., Gerald F. Watts, Yaffa Rubinstein, et al.. (2013). Role of international registries in enhancing the care of familial hypercholesterolaemia. International Journal of Evidence-Based Healthcare. 11(2). 134–139. 22 indexed citations
11.
Moore, Helen M., Andréa B. Kelly, Scott D. Jewell, et al.. (2011). Biospecimen reporting for improved study quality (BRISQ). Cancer Cytopathology. 119(2). 92–102. 129 indexed citations
12.
Rubinstein, Yaffa, Stephen C. Groft, Ronald Christensen, et al.. (2010). Creating a global rare disease patient registry linked to a rare diseases biorepository database: Rare Disease-HUB (RD-HUB). Contemporary Clinical Trials. 31(5). 394–404. 71 indexed citations
13.
Forrest, Christopher B., et al.. (2010). The case for a global rare-diseases registry. The Lancet. 377(9771). 1057–1059. 59 indexed citations
14.
Rubinstein, Yaffa, Takashi Furusawa, Jae‐Hwan Lim, et al.. (2005). Chromosomal protein HMGN1 modulates the expression of N‐cadherin. FEBS Journal. 272(22). 5853–5863. 21 indexed citations
15.
Lim, Jae‐Hwan, Katherine L. West, Yaffa Rubinstein, et al.. (2005). Chromosomal protein HMGN1 enhances the acetylation of lysine 14 in histone H3. The EMBO Journal. 24(17). 3038–3048. 79 indexed citations
16.
Ettenberg, Seth A., Alessandra Magnifico, Mauricio Cuello, et al.. (2001). Cbl-b-dependent Coordinated Degradation of the Epidermal Growth Factor Receptor Signaling Complex. Journal of Biological Chemistry. 276(29). 27677–27684. 125 indexed citations
17.
Rubinstein, Yaffa & Carol H. Pontzer. (2000). Loss of interferon alpha and interferon tau-induced antiviral protection in interferon regulatory factor-2 DNA-binding domain dominant negative mutants. Antiviral Research. 46(3). 207–213. 2 indexed citations
18.
Rubinstein, Yaffa, Paul H. Driggers, Vasily Ogryzko, et al.. (2000). An IFN regulatory factor-2 DNA-binding domain dominant negative mutant exhibits altered cell growth and gene expression. Oncogene. 19(11). 1411–1418. 6 indexed citations
19.
Keane, Maccon, Yaffa Rubinstein, Mauricio Cuello, et al.. (2000). Inhibition of NF-κB Activity Enhances TRAIL Mediated Apoptosis in Breast Cancer Cell Lines. Breast Cancer Research and Treatment. 64(2). 211–219. 87 indexed citations
20.
Reed, Andre L., Hitoshi Yamazaki, Joshua D. Kaufman, et al.. (1998). Molecular Cloning and Characterization of a Transcription Regulator with Homology to GC-binding Factor. Journal of Biological Chemistry. 273(34). 21594–21602. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stella Somiari Breakdown of academic impact, for papers by Helen M. Moore Breakdown of academic impact, for papers by Paul R. Billings Breakdown of academic impact, for papers by Yineng Fu Breakdown of academic impact, for papers by Faina Linkov Breakdown of academic impact, for papers by Manabu Kuroki Breakdown of academic impact, for papers by Manuel M. Morente Breakdown of academic impact, for papers by Qiushi Lin Breakdown of academic impact, for papers by Samuel L. Volchenboum Breakdown of academic impact, for papers by Jim Vaught
Rankless by CCL
2026